Abrisqueta, P., Karimi, Y. H., Morillo, D., Cordoba, R., Phillips, T., de Vos, S., Nijland, M., Offner, F., Andersson, P.-O., Brody, J., Cheah, C. Y., Prieto, P. G., Hellström, M., Jørgensen, J. M., Lewis, D., Linton, K. M., Musuraca, G., Wang, L., Marek, J., Osei-Bonsu, K., Risum, M. and Falchi, L. (2020) “Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300086.